Sareum Holdings plc is a structure-based drug discovery business headquartered in Cambridge, UK. Sareum Limited was formed in August 2003 to discover new drugs for the treatment of cancer and to provide a range of drug discovery services to the
pharmaceutical industry. Sareum's unique approach aims to halve the time it takes to discover new drug candidates. A structure-based approach to drug discovery relies on knowledge of the three-dimensional structure of the proteins that cause disease. Once
the structure is known, potential drugs are designed to 'lock-in' to the protein with the aim of reversing or arresting a disease's progression.…
read more
or
contribute
